Coffee consumption prevents fibrosis in a rat model that mimics secondary biliary cirrhosis in humans
- PMID: 28473062
- DOI: 10.1016/j.nutres.2017.03.008
Coffee consumption prevents fibrosis in a rat model that mimics secondary biliary cirrhosis in humans
Abstract
Investigations demonstrated that oxidative stress plays an important role in injury promotion in cholestatic liver disease. We hypothesized that coffee attenuates cholestasis-induced hepatic necrosis and fibrosis via its antioxidant, anti-inflammatory, and antifibrotic properties. The major aim of this study was to evaluate the hepatoprotective properties of coffee and caffeine in a model of chronic bile duct ligation (BDL) in male Wistar rats. Liver injury was induced by 28-day BDL, and conventional coffee, decaffeinated coffee, or caffeine was administered daily. After treatment, the hepatic oxidative status was estimated by measuring lipid peroxidation, the reduced to oxidized glutathione ratio, and glutathione peroxidase. Fibrosis was assessed by measuring the liver hydroxyproline content. The transforming growth factor-β, connective tissue growth factor, α-smooth muscle actin, collagen 1, and interleukin-10 proteins and mRNAs were measured by Western blot and polymerase chain reaction, respectively. Conventional coffee suppressed most of the changes produced by BDL; however, caffeine showed better antifibrotic effects. Coffee demonstrated antioxidant properties by restoring the redox equilibrium, and it also prevented the elevation of liver enzymes as well as hepatic glycogen depletion. Interestingly, coffee and caffeine administration prevented collagen increases. Western blot assays showed decreased expression levels of transforming growth factor-β, connective tissue growth factor, α-smooth muscle actin, and collagen 1 in the coffee- and caffeine-treated BDL groups. Similarly, coffee decreased the mRNA levels of these proteins. We conclude that coffee prevents liver cirrhosis induced by BDL by attenuating the oxidant processes, blocking hepatic stellate cell activation, and downregulating the main profibrotic molecules involved in extracellular matrix deposition.
Keywords: CTGF; Cirrhosis; Coffee; Oxidative stress; TGF-β.
Copyright © 2017 Elsevier Inc. All rights reserved.
Similar articles
-
Coffee attenuates fibrosis by decreasing the expression of TGF-β and CTGF in a murine model of liver damage.J Appl Toxicol. 2013 Sep;33(9):970-9. doi: 10.1002/jat.2788. Epub 2012 Aug 17. J Appl Toxicol. 2013. PMID: 22899499
-
Caffeine prevents experimental liver fibrosis by blocking the expression of TGF-β.Eur J Gastroenterol Hepatol. 2014 Feb;26(2):164-73. doi: 10.1097/MEG.0b013e3283644e26. Eur J Gastroenterol Hepatol. 2014. PMID: 23903851
-
Trolox mitigates fibrosis in a bile duct ligation model.Fundam Clin Pharmacol. 2013 Jun;27(3):308-18. doi: 10.1111/j.1472-8206.2011.01020.x. Epub 2011 Dec 27. Fundam Clin Pharmacol. 2013. PMID: 22211361
-
Peribiliary myofibroblasts in biliary type liver fibrosis.Front Biosci. 2002 Feb 1;7:d496-503. doi: 10.2741/A790. Front Biosci. 2002. PMID: 11815289 Review.
-
Beneficial effects of naringenin in liver diseases: Molecular mechanisms.World J Gastroenterol. 2018 Apr 28;24(16):1679-1707. doi: 10.3748/wjg.v24.i16.1679. World J Gastroenterol. 2018. PMID: 29713125 Free PMC article. Review.
Cited by
-
Andrographolide impairs alpha-naphthylisothiocyanate-induced cholestatic liver injury in vivo.J Nat Med. 2019 Mar;73(2):388-396. doi: 10.1007/s11418-018-01275-3. Epub 2019 Jan 7. J Nat Med. 2019. PMID: 30617707
-
Coffee Consumption and Prevention of Cirrhosis: In Support of the Caffeine Hypothesis.Gene Expr. 2018 Mar 21;18(1):1-3. doi: 10.3727/105221617X15046391179559. Epub 2017 Sep 11. Gene Expr. 2018. PMID: 28893365 Free PMC article. Review.
-
Habitual coffee intake and risk for nonalcoholic fatty liver disease: a two-sample Mendelian randomization study.Eur J Nutr. 2021 Jun;60(4):1761-1767. doi: 10.1007/s00394-020-02369-z. Epub 2020 Aug 27. Eur J Nutr. 2021. PMID: 32856188 Free PMC article.
-
Caffeine Inhibits NLRP3 Inflammasome Activation by Downregulating TLR4/MAPK/NF-κB Signaling Pathway in an Experimental NASH Model.Int J Mol Sci. 2022 Sep 1;23(17):9954. doi: 10.3390/ijms23179954. Int J Mol Sci. 2022. PMID: 36077357 Free PMC article.
-
Advances in therapeutic options for portal hypertension.Therap Adv Gastroenterol. 2018 Nov 25;11:1756284818811294. doi: 10.1177/1756284818811294. eCollection 2018. Therap Adv Gastroenterol. 2018. PMID: 30505350 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous